Rare diseases
Investigational molecules
Locations
Back to Germany1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
GermanyA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
GermanyA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
GermanyA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
GermanyStudy of Telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
GermanyStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
GermanyStudy on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer
GermanyStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
GermanyPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
GermanyPhase 3 Randomized Double‑Blind Study of Pitolisant versus Placebo for Safety and Efficacy in Adults with Idiopathic Hypersomnia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on various cancer types, including metastatic prostate cancer, colorectal cancer, and bladder cancer. Novel therapeutic approaches combining immunotherapy with established treatments are being investigated.
Research aims to improve survival rates and treatment effectiveness through targeted therapies and immunological approaches.
Important research in heart disease and blood conditions, including studies on TTR amyloidosis and prevention of thrombotic events. Novel medications are being tested to improve patient outcomes.
Focus on developing innovative treatments for complex cardiovascular conditions and preventing blood clots.
Advanced research into neurological conditions, particularly focusing on Alzheimer's disease and autoimmune dementia. Studies aim to develop new therapeutic approaches and improve diagnostic tools.
Innovative approaches to treating and managing neurodegenerative conditions.
Critical research in HIV prevention and immune system modulation, including studies on transplant medicine and vaccine development for yellow fever.
Focus on preventing infectious diseases and improving transplant outcomes through immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
